IGF2BP2 and rectal cancer: Interestingly, SFN and IGF2BP2, which were more highly expressed in the metastases of poor-outcome patient I, were also associated with shorter overall survival in a large cohort (n = 165) of rectal cancer patients based on data from the Kaplan–Meier plotter database [25].